Zespri sets out road to recovery from Psa disease

Zespri has confirmed its plans to help lead the New Zealand kiwifruit industry to recovery from Psa disease.

It is replacing the original Zespri Gold variety, Hort16A, with Gold3, which has so far shown greater levels of Psa tolerance.

Growers that have a Hort16A production licence will have access to Gold3 licences if they choose to switch.

But chairman John Loughlin warned: “Zespri is being very clear to growers that this pathway is not without risk.”